Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

NCT03112668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-04-08

No results posted yet for this study

Summary

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept negative thoughts and feelings and how to live in the present without worrying about the future or past may improve coping skills in patients with stage III-IV cancer and their partners.

Conditions

  • Malignant Female Reproductive System Neoplasm
  • Malignant Hepatobiliary Neoplasm
  • Partner
  • Stage III Breast Cancer
  • Stage III Cervical Cancer
  • Stage III Colorectal Cancer
  • Stage III Lung Cancer
  • Stage III Prostate Cancer
  • Stage III Skin Melanoma
  • Stage III Uterine Corpus Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIA Cervical Cancer
  • Stage IIIA Colorectal Cancer
  • Stage IIIA Lung Carcinoma
  • Stage IIIA Skin Melanoma
  • Stage IIIA Uterine Corpus Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIB Cervical Cancer
  • Stage IIIB Colorectal Cancer
  • Stage IIIB Lung Carcinoma
  • Stage IIIB Skin Melanoma
  • Stage IIIB Uterine Corpus Cancer
  • Stage IIIC Breast Cancer
  • Stage IIIC Colorectal Cancer
  • Stage IIIC Skin Melanoma
  • Stage IIIC Uterine Corpus Cancer
  • Stage IV Breast Cancer
  • Stage IV Cervical Cancer
  • Stage IV Colorectal Cancer
  • Stage IV Lung Cancer
  • Stage IV Prostate Cancer
  • Stage IV Skin Melanoma
  • Stage IV Uterine Corpus Cancer
  • Stage IVA Cervical Cancer
  • Stage IVA Colorectal Cancer
  • Stage IVA Uterine Corpus Cancer
  • Stage IVB Cervical Cancer
  • Stage IVB Colorectal Cancer
  • Stage IVB Uterine Corpus Cancer

Interventions

BEHAVIORAL

Cognitive Behavior Therapy

Undergo ACT

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Sharon Manne · Rutgers Cancer Institute of New Jersey

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-06
Primary Completion
2018-01-25
Completion
2018-01-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03112668 on ClinicalTrials.gov